Artemid supports Biotech Dental
The Artemid Senior Loan III fund is providing €20 million in financing that will enable the company to continue its international growth, particularly in the United States where the company has just acquired IDS, the last major independent distributor of dental implants.
Biotech Dental’s strategy is based on continuous innovation in both software and digital manufacturing processes.
This technological culture has enabled the group to build an offer of high quality products at affordable prices, 100% “Made in France”, in their manufacturing centers in the Arve Valley (Rhône-Alpes) and Salon-de-Provence, where its head office is also located.
The funds in the Artemid range are managed by the asset management company CAPZA as well as a third party portfolio management company and advised by Artemid SAS, a joint subsidiary of CAPZA and Amiral Gestion. Artemid SAS is a financial investment advisor (conseiller en investissement financier – CIF) registered at the ORIAS under the number 14003497 since 5/28/2014.
-
9Apr’ 2024Objectif CRPE welcomes CAPZA Transition as a shareholderCAPZA supports Objectif CRPE in its development strategyRead more
-
13Mar’ 2024CAPZA's vision on 2024 market outlookChristophe Karvelis-Senn, President of CAPZA, Maxence Radix, Benoit Choppin and Guillaume de Jongh, Managing Partners of CAPZA, share their vision for 2024.Read more
-
28Feb’ 2024CAPZA accelerates the development of bnetworkCAPZA has entered into exclusive negotiations to acquire a minority stake in bnetworkRead more
-
28Feb’ 2024Gainerie 91 welcomes CAPZA Transition as a shareholderCAPZA supports Gainerie 91 in its development strategyRead more